THRIFTY PAYLESS INC
10-Q, 1996-08-13
DRUG STORES AND PROPRIETARY STORES
Previous: DW BANKSHARES INC, 8-K, 1996-08-13
Next: AMERICAN RESTAURANT GROUP HOLDINGS INC, 10-Q, 1996-08-13



           UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                    Washington, D. C.   20549
                ____________________________________

                            Form 10-Q


        [X]  QUARTERLY REPORT PURSUANT TO SECTION 13 or 15 (d)
             OF THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended June 30, 1996

                                   OR

        [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 or 15 (d)
             OF THE SECURITIES EXCHANGE ACT OF 1934

               For the transition period from  ________ to ________

                    Commission File Number 33-73592   

                          _______________________

                           THRIFTY PAYLESS, INC.
           (Exact name of registrant as specified in its charter)

         California                                 95-4391249
(State or other jurisdiction of                  (I.R.S. Employer
 incorporation or organization)                   Identification No.)

         9275 Southwest Peyton Lane, Wilsonville, Oregon 97070
         (Address of principal executive offices and zip code)

                             (503) 682-4100
            Registrant's telephone number, including area code
                          ______________________

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.  Yes  [X]   No [ ]            

 Shares of common stock outstanding at August 9, 1996 - 1,000


<PAGE>    
                             PART 1.    FINANCIAL INFORMATION

Item 1.  Financial Statements

                            
                              THRIFTY PAYLESS, INC. AND SUBSIDIARIES
                          CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                          (UNAUDITED)

                                     (Dollars in millions)
<TABLE>
<CAPTION>
                                        For the 13 Week    For the 13 Week   For the 39 Week   For the 39 Week
                                         Period Ended       Period Ended      Period Ended      Period Ended
                                         June 30, 1996      July 2, 1995      June 30, 1996     July 2, 1995  
                                        ----------------   ---------------   ----------------  ---------------
<S>                                       <C>                <C>               <C>               <C>
Sales .................................   $   1,213.4        $   1,172.7       $   3,643.6       $    3,572.2
Cost of goods sold, buying and
   occupancy ..........................         895.3              860.1           2,673.8            2,609.4
                                           ------------       -----------       ------------      ------------
      Gross profit ....................         318.1              312.6             969.8              962.8
Costs and expenses:
  Selling and administration ..........         259.7              264.0             781.1              807.6
  Depreciation and Amortization .......          16.9               16.1              51.8               48.3
                                           ------------       -----------       ------------      ------------
      Operating profit ................          41.5               32.5             136.9              106.9
Interest expense, net .................          23.2               29.8              83.9               88.9
                                           ------------       -----------       ------------      ------------
      Income before income taxes
          and extraordinary loss ......          18.3                2.7              53.0               18.0
Income tax expense ....................           7.8                1.4              22.6                9.5
                                           ------------       -----------       ------------      ------------
      Income before extraordinary      
          loss ........................          10.5                1.3              30.4                8.5
Extraordinary loss on early      
   extinguishment of debt, net of
   tax benefit of $4.6 ................          90.3                --               90.3                --
                                           ------------       -----------       ------------      ------------
             Net income (loss) ........   $     (79.8)       $       1.3       $     (59.9)      $        8.5
                                           ============       ===========       ============      ============


</TABLE>


         See accompanying Notes to Condensed Consolidated Financial Statement


<PAGE>  
                             THRIFTY PAYLESS, INC. AND SUBSIDIARIES
                              CONDENSED CONSOLIDATED BALANCE SHEETS
                                          (UNAUDITED)

                                       (Dollars in millions)

                                           ASSETS
<TABLE>
<CAPTION>
                                                     June 30,      October 1,
                                                       1996          1995
                                                   ------------   ------------
<S>                                                 <C>            <C>
Current assets:
   Receivables .................................    $     98.6     $     82.6
   Inventories .................................       1,097.0        1,160.7
   Prepaid expenses and other current assets ...          34.3           42.8
                                                     ----------     ----------
       Total current assets ....................       1,229.9        1,286.1
Property, plant and equipment, net .............         560.1          581.9
Leasehold interests, net .......................          88.4           94.1
Deferred income taxes ..........................          23.9           15.8
Other assets ...................................          99.4          118.4
                                                     ----------     ----------
                                                    $  2,001.7     $  2,096.3
                                                     ==========     ========== 


                        LIABILITIES AND SHAREHOLDER'S EQUITY

Current liabilities:
   Current maturities of long-term debt ........    $     28.4     $     27.1
   Accounts payable ............................         288.4          342.7
   Accrued expenses ............................         204.9          260.4
   Deferred income taxes .......................         169.4          146.6
                                                     ----------     ----------
       Total current liabilities ...............         691.1          776.8
Long-term debt, excluding current maturities ...         836.0          913.2
Other long-term liabilities ....................         120.9          111.4
                                                     ----------     ----------
       Total liabilities                               1,648.0        1,801.4
                                                     ----------     ----------

Commitments and Contingencies

Shareholder's equity:
   Common stock ................................           --             -- 
   Additional paid-in capital ..................         411.4          292.7
   Accumulated earnings (deficit) ..............         (57.7)           2.2 
                                                     ----------     ----------
       Total shareholder's equity ..............         353.7          294.9
                                                     ----------     ----------
                                                    $  2,001.7     $  2,096.3
                                                     ==========     ==========
</TABLE>
        See accompanying Notes to Condensed Consolidated Financial Statements


<PAGE>   
                             THRIFTY PAYLESS, INC. AND SUBSIDIARIES
                         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                          (UNAUDITED)

                                       (Dollars in millions)
<TABLE>
<CAPTION>
                                                   For the 39 Week    For the 39 Week
                                                    Period Ended       Period Ended 
                                                    June 30, 1996      July 2, 1995 
                                                   ---------------    ---------------
<S>                                                  <C>                <C>    
Operating activities:
  Net income (loss).............................     $     (59.9)       $      8.5
  Adjustments to reconcile net income (loss) to 
   net cash provided by (used in) operating
   activities:
     Depreciation and amortization .............            51.8              48.3
     Debt discount and fee amortization ........             6.2               6.6
     Deferred tax provision ....................            19.4              (2.7)
     Loss (gain) on sale of assets .............            (3.7)              0.2
     Extraordinary loss on early extinguishment
       of debt .................................            90.3               --
Changes in operating assets and liabilities:                                    
  Receivables ..................................           (15.9)             (3.1)
  Inventories ..................................            63.7              71.2
  Prepaid expenses and other current assets ....             8.5             (12.5)
  Accounts payable .............................           (54.3)           (117.7)  
  Accrued expenses and other liabilities .......           (43.9)            (48.1)   
                                                      -----------         ----------
       Net cash provided by (used in) operating                                 
           activities ..........................            62.2             (49.3)
                                                      -----------         ----------
Investing activities:
  Purchases of property, plant and equipment ...           (28.8)            (44.2)
  Proceeds from disposition of properties ......            12.4              22.1
  Increase in other assets .....................            (8.1)             (5.7)
                                                      -----------         ----------
       Net cash used in investing activities ...           (24.5)            (27.8)
                                                      -----------         ----------

Financing activities:
  New borrowings ...............................           708.6              99.0
  Capital contribution from parent company .....           118.7               --  
  Repayment of long-term debt and bank fees ....          (865.0)            (25.9)
                                                      -----------         ----------
       Net cash provided by (used in) financing                                 
           activities ..........................           (37.7)             73.1
                                                      -----------         ----------
Increase (decrease) in cash and cash 
  equivalents ..................................             --               (4.0)
Cash and cash equivalents, beginning of period .             --                4.0
                                                      -----------         ----------
Cash and cash equivalents, end of period .......     $       --         $       --  
                                                      ===========         ==========
</TABLE>
        See accompanying Notes to Condensed Consolidated Financial Statement


<PAGE>               
                     THRIFTY PAYLESS, INC. AND SUBSIDIARIES

            NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                              (UNAUDITED)

                         

(1)	The condensed consolidated financial statements have been prepared by 
Thrifty PayLess, Inc. (the "Company" or "TPI"), without audit, in accordance 
with generally accepted accounting principles.  Pursuant to the rules and 
regulations of the Securities and Exchange Commission, certain information 
and footnote disclosures normally included in consolidated financial 
statements prepared in accordance with generally accepted accounting 
principles have been omitted or condensed.  It is management's belief that 
the disclosures made are adequate to make the information presented not 
misleading and reflect all adjustments (consisting only of normal recurring 
adjustments) necessary for a fair presentation of financial position and 
results of operations for the periods presented.  The results of operations 
for the periods presented should not necessarily be considered indicative of 
operations for the full year.  It is recommended that these condensed 
consolidated financial statements be read in conjunction with the 
consolidated financial statements for the year ended October 1, 1995 and the 
notes thereto included in the Company's 10-K.

(2)	Certain reclassifications have been made to prior period financial 
statements in order to conform to the current period presentation.

(3)	The condensed consolidated financial statements have been prepared using 
the last-in, first-out (LIFO) method of accounting for inventories.   If 
these inventories had been valued using the first-in, first-out (FIFO) method 
of inventory valuation, the inventory values would have been approximately 
$23.3 million and $8.2 million higher at June 30, 1996 and October 1, 1995, 
respectively.  The charge to cost of goods sold for LIFO valuation for the 13 
week periods ended June 30, 1996 and July 2, 1995, and the 39 week periods 
ended June 30, 1996 and July 2, 1995 was $4.2 million, $2.6 million, $15.1 
million and $7.8 million, respectively.  A final valuation of inventory under 
the LIFO method can be made only after year-end based on ending inventory 
levels and inflation rates for the year.  Interim LIFO calculations are based 
upon management's estimates of year-end inventory levels and inflation rates 
for the year.


<PAGE>               
                       THRIFTY PAYLESS, INC. AND SUBSIDIARIES

            NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                              (UNAUDITED)


(4)   In April 1996, the Company, a wholly owned subsidiary of Thrifty 
PayLess Holdings, Inc. ("TPH"), and TPH implemented a recapitalization plan 
(the "Recapitalization") designed to reduce indebtedness and interest 
expense, improve operating and financial flexibility and increase 
stockholders' equity.  The Recapitalization includes the following 
components: (i) the offering of 24.3 million of TPH's Class B common stock 
with net proceeds to TPH of approximately $307.3 million; (ii) the 
redemptions, with proceeds of the offering, of $105.0 million in outstanding 
principal amount of the Company's 12 1/4% Senior Subordinated Notes due 2004 
and $175.5 million in outstanding principal amount of TPH's 11 5/8% Senior 
Notes due 2006 (the "PIK Notes"); (iii) the repurchase, with proceeds of the 
offering, of $12.8 million of the remaining outstanding principal amount of 
PIK Notes that were not redeemable; (iv) the repurchase, with borrowings 
under the new bank facility (the "New Bank Facility") of $249.6 million in 
outstanding principal amount of TPI's 11 3/4% Senior Notes due 2003; and, (v) 
the procurement of the $1 billion New Bank Facility which (a) refinanced the 
Company's existing indebtedness under its Credit Agreement ("Old Bank 
Facility"), dated July 20, 1994, as amended, (b) provided financing used to 
repurchase the 11 3/4% Senior Notes and, (c) provided for a lower interest 
rate on the Company's indebtedness.  Under the Old Bank Facility, interest 
rates were at LIBOR plus a spread ranging between 2.625% and 3.375% with 
respect to various tranches.  The New Bank Facility interest rate is LIBOR 
plus 1.50%, subject to reduction upon achieving certain performance measures.  
As a result of the Recapitalization, the Company incurred an extraordinary 
charge in the third quarter of $90.3 million (net of a $4.6  million tax 
benefit) to write-off deferred financing fees, original issue discounts, 
consent fees, premiums, and other expenses.


<PAGE>  
Item 2:		Management's Discussion and Analysis of Financial
			       Condition and Results of Operations


RESULTS OF OPERATIONS

13 Week Period Ended June 30, 1996 ("third quarter 1996") compared with the 
13 Week Period Ended July 2, 1995 ("third quarter 1995")

	Sales for third quarter 1996 were $1,213.4 million compared to 
$1,172.7 million for third quarter 1995, an increase of $40.7 million or 
3.5%.  The Company operated 1,049 stores as of June 30, 1996 versus 1,040 
stores as of July 2, 1995. Total same-store sales increased by 2.9% compared 
to third quarter 1995 with a 12.8% increase in pharmacy sales and a 1.7% 
decrease in non-pharmacy sales.  

	Pharmacy sales as a percentage of total sales were approximately 34.0% 
for third quarter 1996 as compared to approximately 31.1% for third quarter 
1995.  The growth in prescription sales was primarily the result of 
increased third-party pharmacy sales.  Third-party pharmacy sales as a 
percentage of total pharmacy sales represented approximately 75.8% for third 
quarter 1996 as compared to approximately 70.5% for third quarter 1995.  The 
Company expects pharmacy sales to third-party payors, in terms of both 
dollar volume and as a percentage of total pharmacy sales, to continue to 
increase in fiscal 1996 and thereafter.

	Gross profit as a percent of sales decreased to 26.2% for third 
quarter 1996 from 26.7% for third quarter 1995.  The decrease resulted 
primarily from continued pressure on pharmacy gross margins related to 
increased lower margin third-party pharmacy sales and an increase in the 
estimated LIFO valuation charge.

	Selling and administrative expenses decreased $4.3 million to $259.7 
million or 21.4% of sales in third quarter 1996 compared with $264.0 million 
or 22.5% of sales in third quarter 1995.  The decrease resulted primarily 
from cost reductions including combined PayLess and Thrifty Drug California  
dual logo advertising programs.  The decrease was partially offset by higher 
store labor expenses.

	Operating profit was $41.5 million for third quarter 1996 compared to 
$32.5 million for third quarter 1995, an increase of $9.0 million or 27.7%.  
The increase is the result of the items discussed above.

	Net interest expense was $23.2 million for third quarter 1996 compared 
to $29.8 million for third quarter 1995, a decrease of $6.6 million.  The 
decrease was primarily a result of the Recapitalization.

	The effective income tax rate, excluding the impact of the 
extraordinary loss, for third quarter 1996 was 42.6% compared to 51.9% in 
third quarter 1995.  The change in the effective tax rate resulted from 
goodwill amortization and other items not deductible for income tax 
purposes.

	During the third quarter, the Company completed the Recapitalization 
as discussed in note 4 to the condensed consolidated financial statements.  
The Recapitalization resulted in a $90.3 million extraordinary loss, net of 
a $4.6 million income tax benefit, to write-off deferred financing fees, 
original issue discounts, consent fees, premiums, and other expenses.
     
	Net loss for third quarter 1996 was $79.8 million compared to net 
income of $1.3 million in third quarter 1995.  The net loss is related to 
the extraordinary loss on the early extinguishment of debt noted above.

	Operating profit plus depreciation and amortization expense and LIFO 
provision (EBITDAL) was $62.6 million or 5.2% of sales in third quarter 
1996, compared to $51.2 million or 4.4% of sales for third quarter 1995.  
EBITDAL IS NOT INTENDED TO REPRESENT CASH FLOW OR ANY MEASURE OF PERFORMANCE 
IN ACCORDANCE WITH GENERALLY ACCEPTED ACCOUNTING PRINCIPLES.  EBITDAL IS 
INCLUDED BECAUSE MANAGEMENT BELIEVES THAT CERTAIN INVESTORS FIND IT USEFUL 
IN MEASURING A COMPANY'S ABILITY TO SERVICE DEBT.

39 Week Period Ended June 30, 1996 ("year-to-date 1996") compared with the 
39 Week Period Ended July 2, 1995 ("year-to-date 1995")

	Sales for year-to-date 1996 were $3,643.6 million compared to $3,572.2 
million for year-to-date 1995, an increase of $71.4 million or 2.0%.  Total 
same-store sales increased by 2.6% compared to year-to-date 1995 with a 
12.1% increase in pharmacy sales and a 1.5% decrease in non-pharmacy sales.  

	Pharmacy sales as a percentage of total sales were approximately 32.9% 
for year-to-date 1996 as compared to approximately 30.1% for year-to-date 
1995.  The growth in prescription sales was primarily the result of 
increased third-party pharmacy sales.  Third-party pharmacy sales as a 
percentage of total pharmacy sales represented approximately 74.3% for year-
to-date 1996 as compared to approximately 69.5% for year-to-date 1995.  The 
Company expects pharmacy sales to third-party payors, in terms of both 
dollar volume and as a percentage of total pharmacy sales, to continue to 
increase in fiscal 1996 and thereafter.

	Gross profit as a percent of sales decreased to 26.6% for year-to-date 
1996 from 27.0% for year-to-date 1995. The decrease results primarily from 
continued pressure on pharmacy gross margins related to increased lower 
margin third-party pharmacy sales and an increase in the estimated LIFO 
valuation charge.

	Selling and administrative expenses decreased $26.5 million to $781.1 
million or 21.4% of sales in year-to-date 1996 compared with $807.6 million 
or 22.6% of sales in year-to-date 1995.  The decrease resulted primarily 
from cost reductions as the Company combined administrative services of 
PayLess and Thrifty Drug stores to one location and combined PayLess and 
Thrifty Drug California dual logo advertising programs.

	Operating profit was $136.9 million for year-to-date 1996 compared to 
$106.9 million for year-to-date 1995, an increase of $30.0 million or 28.1%.  
The increase is the result of the items discussed above.

	Net interest expense was $83.9 million for year-to-date 1996 compared 
to $88.9 million for year-to-date 1995.  The decrease was primarily the 
result of the Recapitalization, partially offset by increased borrowings 
under the revolving line of credit during the first half of the year.

	The effective income tax rate, excluding the impact of the 
extraordinary loss, for year-to-date 1996 was 42.6% compared to 52.8% in 
year-to-date 1995.  The change in the effective tax rate resulted from 
goodwill amortization and other items not deductible for income tax 
purposes.

	During the third quarter, the Company completed the Recapitalization, 
which resulted in a $90.3 million extraordinary loss,  net of a $4.6 million 
tax benefit, to write-off deferred financing fees, original issue discounts, 
consent fees, premiums, and other expenses.

	Net loss for year-to-date 1996 was $59.9 million compared to net 
income of $8.5 million for year-to-date 1995.  The net loss is attributable 
to the extraordinary loss on the early extinguishment of debt noted above.

	EBITDAL was $203.8 million or 5.6% of sales in year-to-date 1996, 
compared to $163.0 million or 4.6% of sales for year-to-date 1995.

LIQUIDITY AND CAPITAL RESOURCES

	The Company's primary sources of liquidity are cash flow from 
operations and a $750.0 million revolving credit facility under the New Bank 
Facility.  Cash requirements are for debt service, capital expenditures and 
working capital.  Working capital requirements follow the seasonal trend of 
the retailing industry, peaking in November.  At August 9, 1996, the Company 
had borrowed $383.8 million and had $125.6 million in letters of credit 
outstanding under the available revolving credit facility.

	Cash provided by operating activities for year-to-date 1996 was $62.2 
million due in part to improved results of operations and a reduction in 
inventory level, partially offset by a decrease in accounts payable 
attributable to seasonality and an increase in receivables related primarily 
to increased pharmacy sales to third-party plans and vendor allowances.  
Cash used in investing activities was $24.5 million with capital 
expenditures of $28.8 million in year-to-date 1996.

	Management believes that cash from operations, combined with 
borrowings under the New Bank Facility and other financing sources will be 
sufficient to enable the Company to meet all of its obligations when due.

	The Company has adopted various tax positions (including the adoption 
of the LIFO method of inventory accounting), which positions it believes 
comply with applicable tax laws and regulations.  However, in the event such 
positions are challenged and are not upheld, there could be a material 
adverse effect on the Company's liquidity and financial condition.  The 
Company's consolidated federal tax returns for the fiscal years 1992 through 
1994 are currently being examined by the Internal Revenue Service.


<PAGE>
PART II.   OTHER INFORMATION

Item 1.    Legal Proceedings

The Company is from time to time involved in litigation 
incidental to the conduct of its business.  Management regularly 
reviews all pending litigation matters in which it is involved 
and establishes reserves deemed appropriate for such litigation 
matters.  Management believes that no such pending litigation 
matters will have a material adverse effect on the Company's 
financial statements taken as a whole.


Item 2.    Changes in Securities
  
           Not applicable

Item 3.    Defaults upon Senior Securities

           Not applicable
		
Item 4.    Submission of Matters to a Vote of Security Holders

           Not applicable

Item 5.    Other Information

           Not applicable

Item 6.    Exhibits and Reports on Form 8-K

          (a)   Exhibits.

                Exhibit 27.    Financial Data Schedule

          (b)   Reports on Form 8-K.
	
           No reports on Form 8-K were filed during this quarter.


<PAGE>
                                   SIGNATURE


	Pursuant to the requirements of the Securities Exchange Act of 1934, 
the registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                 THRIFTY PAYLESS, INC.


Date:	 August 12, 1996            /s/David R. Jessick			
                                 --------------------
                                 David R. Jessick  
                                 Executive Vice President,
                                 Chief Financial Officer and officer
                                 duly authorized to sign this Form 10-Q


<PAGE>
                                 EXHIBIT INDEX

Exhibit No.                      Description                          Page
- -----------                      ------------------------------       ----
EX-27                            Financial Data Schedule


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Condensed Consolidated Balance Sheet at June 30, 1996 (unaudited) and the
Condensed Consolidated Statement of Operations for the 39 week period ended
June 30, 1996 (unaudited), and is qualified in its entirety by reference to
such financial statements.
</LEGEND>
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-29-1996
<PERIOD-START>                             OCT-02-1995
<PERIOD-END>                               JUN-30-1996
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                    98600
<ALLOWANCES>                                         0
<INVENTORY>                                    1097000
<CURRENT-ASSETS>                               1229900
<PP&E>                                          560100
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 2001700
<CURRENT-LIABILITIES>                           691100
<BONDS>                                         836000
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                      353700
<TOTAL-LIABILITY-AND-EQUITY>                   2001700
<SALES>                                        3643600
<TOTAL-REVENUES>                               3643600
<CGS>                                          2673800
<TOTAL-COSTS>                                  2673800
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               83900
<INCOME-PRETAX>                                  53000
<INCOME-TAX>                                     22600
<INCOME-CONTINUING>                              30400
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  90300
<CHANGES>                                            0
<NET-INCOME>                                   (59900)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission